| General Information |
| Business: |
(Incorporated in Delaware)
We are a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs.
Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500 companies.
Note: Net loss and revenue are for the year that ended Dec. 31, 2024.
(Note: Omada Health disclosed the terms for its IPO in an S-1/A filing dated May 29, 2025: The company is offering 7.9 million shares at a price range of $18.00 to $20.00 to raise $150.1 million, if priced at the $19.00 mid-point of its range.)
|
| Industry: |
Health Services - Virtual Healthcare |
| Employees: |
849 |
| Founded: |
2011 |
| Contact Information |
| Address |
500 Sansome Street, Suite 200 San Francisco, California 94111 |
| Phone Number |
(888) 987-8337 |
| Web Address |
http://www.omadahealth.com/ |
| View Prospectus: |
Omada Health |
| Financial Information |
| Market Cap |
$1059.14mil |
| Revenues |
$169.8 mil (last 12 months) |
| Net Income |
$-47.1 mil (last 12 months) |
| IPO Profile |
| Symbol |
OMDA |
| Exchange |
NASDAQ |
| Shares (millions): |
7.9 |
| Price range |
$18.00 - $20.00 |
| Est. $ Volume |
$150.1 mil |
| Manager / Joint Managers |
Morgan Stanley/Goldman Sachs/J.P.Morgan/Barclays/Evercore ISI |
| CO-Managers |
Canaccord Genuity/Needham & Co. |
| Expected To Trade: |
6/6/2025 |
|
Day:
|
Friday |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
